US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist
  • 4.150
  • -0.440-9.59%
Close Mar 26 16:00 ET
  • 4.150
  • 0.0000.00%
Post 16:05 ET
235.57MMarket Cap-4.72P/E (TTM)

Design Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-20.22%62.38M
10.40%16.69M
-13.69%16.25M
-33.43%15.04M
-33.49%14.4M
15.68%78.19M
-22.02%15.12M
-1.93%18.82M
44.48%22.6M
61.94%21.65M
Selling and administrative expenses
-14.64%18.03M
10.42%4.54M
-21.47%4.37M
-18.17%4.53M
-22.33%4.6M
11.31%21.13M
-20.01%4.11M
13.85%5.57M
27.35%5.53M
28.41%5.92M
-General and administrative expense
-14.64%18.03M
10.42%4.54M
-21.47%4.37M
-18.17%4.53M
-22.33%4.6M
11.31%21.13M
-20.01%4.11M
13.85%5.57M
27.35%5.53M
28.41%5.92M
Research and development costs
-22.28%44.35M
10.40%12.16M
-10.42%11.88M
-38.37%10.52M
-37.69%9.8M
17.38%57.06M
-22.75%11.01M
-7.32%13.26M
51.08%17.06M
79.59%15.73M
Operating profit
20.22%-62.38M
-10.40%-16.69M
13.69%-16.25M
33.43%-15.04M
33.49%-14.4M
-15.68%-78.19M
22.02%-15.12M
1.93%-18.82M
-44.48%-22.6M
-61.94%-21.65M
Net non-operating interest income expense
12.95%12.8M
11.33M
Non-operating interest income
12.95%12.8M
----
----
----
----
--11.33M
----
----
----
----
Other net income (expense)
5.74%3.21M
22.23%3.25M
39.80%3.3M
103.83%3.03M
315.47%2.66M
2,144.76%2.36M
Other non- operating income (expenses)
----
----
5.74%3.21M
22.23%3.25M
39.80%3.3M
----
----
103.83%3.03M
315.47%2.66M
2,144.76%2.36M
Income before tax
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
Income tax
Net income
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
Net income continuous Operations
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
Minority interest income
Net income attributable to the parent company
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
25.84%-49.59M
-15.28%-13.65M
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
Basic earnings per share
26.05%-0.88
-14.29%-0.24
17.86%-0.23
41.67%-0.21
42.86%-0.2
-4.39%-1.19
32.26%-0.21
12.50%-0.28
-33.33%-0.36
-45.83%-0.35
Diluted earnings per share
26.05%-0.88
-14.29%-0.24
17.86%-0.23
41.67%-0.21
42.86%-0.2
-4.39%-1.19
32.26%-0.21
12.50%-0.28
-33.33%-0.36
-45.83%-0.35
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -20.22%62.38M10.40%16.69M-13.69%16.25M-33.43%15.04M-33.49%14.4M15.68%78.19M-22.02%15.12M-1.93%18.82M44.48%22.6M61.94%21.65M
Selling and administrative expenses -14.64%18.03M10.42%4.54M-21.47%4.37M-18.17%4.53M-22.33%4.6M11.31%21.13M-20.01%4.11M13.85%5.57M27.35%5.53M28.41%5.92M
-General and administrative expense -14.64%18.03M10.42%4.54M-21.47%4.37M-18.17%4.53M-22.33%4.6M11.31%21.13M-20.01%4.11M13.85%5.57M27.35%5.53M28.41%5.92M
Research and development costs -22.28%44.35M10.40%12.16M-10.42%11.88M-38.37%10.52M-37.69%9.8M17.38%57.06M-22.75%11.01M-7.32%13.26M51.08%17.06M79.59%15.73M
Operating profit 20.22%-62.38M-10.40%-16.69M13.69%-16.25M33.43%-15.04M33.49%-14.4M-15.68%-78.19M22.02%-15.12M1.93%-18.82M-44.48%-22.6M-61.94%-21.65M
Net non-operating interest income expense 12.95%12.8M11.33M
Non-operating interest income 12.95%12.8M------------------11.33M----------------
Other net income (expense) 5.74%3.21M22.23%3.25M39.80%3.3M103.83%3.03M315.47%2.66M2,144.76%2.36M
Other non- operating income (expenses) --------5.74%3.21M22.23%3.25M39.80%3.3M--------103.83%3.03M315.47%2.66M2,144.76%2.36M
Income before tax 25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M
Income tax
Net income 25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M
Net income continuous Operations 25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M
Minority interest income
Net income attributable to the parent company 25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 25.84%-49.59M-15.28%-13.65M17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M
Basic earnings per share 26.05%-0.88-14.29%-0.2417.86%-0.2341.67%-0.2142.86%-0.2-4.39%-1.1932.26%-0.2112.50%-0.28-33.33%-0.36-45.83%-0.35
Diluted earnings per share 26.05%-0.88-14.29%-0.2417.86%-0.2341.67%-0.2142.86%-0.2-4.39%-1.1932.26%-0.2112.50%-0.28-33.33%-0.36-45.83%-0.35
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Constellation Brands
STZ
+3.22%
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+3.05%
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
+2.49%
Precision Drilling
PDS
+0.43%
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
0.00%

Unlock the Full List